Cargando…
Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein
BACKGROUND: Natural killer and cytotoxic CD8(+) T cells are major players during antitumor immunity. They express NKG2D, an activating receptor that promotes tumor elimination through recognition of the MHC class I chain-related proteins A and B (MICA and MICB). Both molecules are overexpressed on a...
Autores principales: | Torres, Nicolas, Regge, María Victoria, Secchiari, Florencia, Friedrich, Adrián David, Spallanzani, Raúl Germán, Raffo Iraolagoitia, Ximena Lucía, Núñez, Sol Yanel, Sierra, Jessica Mariel, Ziblat, Andrea, Santilli, María Cecilia, Gilio, Nicolás, Almada, Evangelina, Lauche, Constanza, Pardo, Romina, Domaica, Carolina Inés, Fuertes, Mercedes Beatriz, Madauss, Kevin Patrick, Hance, Kenneth W, Gloger, Israel S, Zylberman, Vanesa, Goldbaum, Fernando Alberto, Zwirner, Norberto Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282397/ https://www.ncbi.nlm.nih.gov/pubmed/32518090 http://dx.doi.org/10.1136/jitc-2019-000233 |
Ejemplares similares
-
The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
por: Secchiari, Florencia, et al.
Publicado: (2022) -
Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1
por: Ziblat, Andrea, et al.
Publicado: (2021) -
Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56(bright) Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation
por: Ziblat, Andrea, et al.
Publicado: (2018) -
Tumor-Experienced Human NK Cells Express High Levels of PD-L1 and Inhibit CD8(+) T Cell Proliferation
por: Sierra, Jessica M., et al.
Publicado: (2021) -
Leveraging NKG2D Ligands in Immuno-Oncology
por: Fuertes, Mercedes Beatriz, et al.
Publicado: (2021)